Search Results - "SCHWÄBLE, J"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Bis(1H-2-indolyl)-1-methanones as inhibitors of the hematopoietic tyrosine kinase Flt3 by TELLER, S, KRÄMER, D, SERVE, H, BÖHMER, F-D, BÖHMER, S-A, TSE, K. F, SMALL, D, MAHBOOBI, S, WALLRAPP, C, BECKERS, T, KRATZ-ALBERS, K, SCHWÄBLE, J

    Published in Leukemia (01-08-2002)
    “…Aberrant expression and activating mutations of the class III receptor tyrosine kinase Flt3 (Flk-2, STK-1) have been linked to poor prognosis in acute myeloid…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Oncogenic receptor tyrosine kinase in leukemia by Mizuki, M, Ueda, S, Matsumura, I, Ishiko, J, Schwäble, J, Serve, H, Kanakura, Y

    “…Growth, survival and differentiation of hematopoietic cells are regulated by the interaction between hematopoietic growth factors and their receptors. While…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Expression of the p14ARF tumor suppressor predicts survival in acute myeloid leukemia by MÜLLER-TIDOW, C, METZELDER, S. K, LUDWIG, W-D, HEINECKE, A, BÜCHNER, T, BERDEL, W. E, SERVE, H, BUERGER, H, PACKEISEN, J, GANSER, A, HEIL, G, KÜGLER, K, ADIGÜZEL, G, SCHWÄBLE, J, STEFFEN, B

    Published in Leukemia (01-04-2004)
    “…Cell cycle aberrations are associated with therapy outcome in many types of cancer. We analyzed mRNA expression levels of 18 cell cycle-related genes in bone…”
    Get full text
    Journal Article
  6. 6

    Neuroblastoma: induction of differentiation (Part I). Basical science in pediatric surgery by Girgert, R, Schweizer, P, Schwäble, J

    Published in European journal of pediatric surgery (01-04-2000)
    “…Neuroblastoma is the second-most common solid tumor in childhood. The majority of patients have a very poor outcome due to aggressive growth and metastatic…”
    Get more information
    Journal Article
  7. 7

    Mutations of growth factor receptor Flt3 in acute myeloid leukemia: transformation of myeloid cells by Ras-dependent and Ras-independent mechanisms by Müller-Tidow, C, Steur, C, Mizuki, M, Schwäble, J, Brandts, C, Berdel, W E, Serve, H

    Published in Deutsche medizinische Wochenschrift (18-10-2002)
    “…The tyrosine kinase receptor Flt3 mediates important functions in early hematopoietic progenitors. Recently mutations of a growth factor receptor have been…”
    Get more information
    Journal Article
  8. 8

    AML-associated Flt3 kinase domain mutations show signal transduction differences compared with Flt3 ITD mutations by Choudhary, Chunaram, Schwäble, Joachim, Brandts, Christian, Tickenbrock, Lara, Sargin, Bülent, Kindler, Thomas, Fischer, Thomas, Berdel, Wolfgang E., Müller-Tidow, Carsten, Serve, Hubert

    Published in Blood (01-07-2005)
    “…Activating mutations of Flt3 are found in approximately one third of patients with acute myeloid leukemia (AML) and are an attractive drug target. Two classes…”
    Get full text
    Journal Article
  9. 9

    Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations by Mizuki, Masao, Schwäble, Joachim, Steur, Claudia, Choudhary, Chunaram, Agrawal, Shuchi, Sargin, Bülent, Steffen, Björn, Matsumura, Itaru, Kanakura, Yuzuru, Böhmer, Frank D., Müller-Tidow, Carsten, Berdel, Wolfgang E., Serve, Hubert

    Published in Blood (15-04-2003)
    “…The receptor tyrosine kinase Flt3 is expressed and functionally important in early myeloid progenitor cells and in the majority of acute myeloid leukemia (AML)…”
    Get full text
    Journal Article
  10. 10

    Flt3 tandem duplication mutations cooperate with Wnt signaling in leukemic signal transduction by Tickenbrock, Lara, Schwäble, Joachim, Wiedehage, Markus, Steffen, Björn, Sargin, Bülent, Choudhary, Chunaram, Brandts, Christian, Berdel, Wolfgang E., Müller-Tidow, Carsten, Serve, Hubert

    Published in Blood (01-05-2005)
    “…Activating Flt3 mutations occur in about 30% of patients with acute myeloid leukemia (AML), often as in-frame internal tandem duplication (ITD) at the…”
    Get full text
    Journal Article
  11. 11

    Identification of metastasis-associated receptor tyrosine kinases in non-small cell lung cancer by MÜLLER-TIDOW, Carsten, DIEDERICHS, Sven, BRANDTS, Christian H, BERDEL, Wolfgang E, SERVE, Hubert, BULK, Etmar, POHLE, Thorsten, STEFFEN, Björn, SCHWÄBLE, Joachim, PLEWKA, Sylvia, THOMAS, Michael, METZGER, Ralf, SCHNEIDER, Paul M

    Published in Cancer research (Chicago, Ill.) (01-03-2005)
    “…Development of distant metastasis after tumor resection is the leading cause of death in early-stage non-small cell lung cancer (NSCLC). Receptor tyrosine…”
    Get full text
    Journal Article
  12. 12

    The molecular pathogenesis of acute myeloid leukemia by Steffen, Björn, Müller-Tidow, Carsten, Schwäble, Joachim, Berdel, Wolfgang E., Serve, Hubert

    Published in Critical reviews in oncology/hematology (01-11-2005)
    “…The description of the molecular pathogenesis of acute myeloid leukemias (AML) has seen dramatic progress over the last years. Two major types of genetic…”
    Get full text
    Journal Article
  13. 13

    RGS2 is an important target gene of Flt3-ITD mutations in AML and functions in myeloid differentiation and leukemic transformation by Schwäble, Joachim, Choudhary, Chunaram, Thiede, Christian, Tickenbrock, Lara, Sargin, Bülent, Steur, Claudia, Rehage, Maike, Rudat, Annika, Brandts, Christian, Berdel, Wolfgang E., Müller-Tidow, Carsten, Serve, Hubert

    Published in Blood (01-03-2005)
    “…Activating fetal liver tyrosine kinase 3 (Flt3) mutations represent the most common genetic aberrations in acute myeloid leukemia (AML). Most commonly, they…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Flt3 receptor tyrosine kinase as a drug target in leukemia by Schmidt-Arras, Dirk, Schwäble, Joachim, Böhmer, Frank-D, Serve, Hubert

    Published in Current pharmaceutical design (01-01-2004)
    “…The hematopoietic class III receptor tyrosine kinase (RTK) Flt3 (Flk2, STK1) has recently received much attention as a potential drug target. Activation of…”
    Get more information
    Journal Article
  16. 16

    The serine-threonine kinase MNK1 is post-translationally stabilized by PML-RARα and regulates differentiation of hematopoietic cells by WORCH, Jennifer, TICKENBROCK, Lara, MÜLLER-TIDOW, Carsten, SCHWÄBLE, Joachim, STEFFEN, Björn, CAUVET, Thomas, MLODY, Barbara, BUERGER, Horst, KOEFFLER, H. Phillip, BERDEL, Wolfgang E, SERVE, Hubert

    Published in Oncogene (09-12-2004)
    “…Microarray analyses were performed to identify target genes that are shared by the acute myeloid leukemia (AML) translocation products PML-RARα, PLZF-RARα and…”
    Get full text
    Journal Article